Piramal Pharma Sees Surge in Open Interest Amid Dynamic Trading Environment
Piramal Pharma Ltd has seen a notable rise in open interest, reaching 6,015 contracts today, alongside a trading volume of 2,771 contracts. Despite a slight decline in stock price, the increase in open interest suggests active trading in the pharmaceuticals and biotechnology sector, indicating heightened market engagement.
Piramal Pharma Ltd (PPLPHARMA) has experienced a significant increase in open interest today, reflecting notable activity in the stock. The latest open interest stands at 6,015 contracts, up from the previous open interest of 5,423, marking a change of 592 contracts or a 10.92% increase. The trading volume for the day reached 2,771 contracts, contributing to a total futures value of approximately Rs 6,631.63 lakhs and an options value of Rs 788.77 crores, bringing the total value to around Rs 6,853.95 lakhs.In terms of price performance, Piramal Pharma's stock has shown a slight decline of 0.47% today, which contrasts with the sector's minor decrease of 0.02% and the broader Sensex's drop of 0.62%. The stock's current price is positioned higher than its 5-day and 20-day moving averages but remains below its 50-day, 100-day, and 200-day moving averages. Additionally, there has been a decrease in delivery volume, which fell by 15.98% compared to the 5-day average, indicating a decline in investor participation.
Overall, the increase in open interest alongside the stock's recent performance highlights a dynamic trading environment for Piramal Pharma, reflecting ongoing market activity within the pharmaceuticals and biotechnology sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
